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ABSTRACT 
 
 Silent Information Regulator 2 (Sir2) of Saccharomyces cerevisiae is the 
progenitor of an ancient family of proteins known as sirtuins. Sirtuins act on 
substrates in various regulatory pathways critical to normal cell function. Human 
SIRT1 is the closest known homologue of yeast Sir2. This study focuses on the 
function of human SIRT1 and the influence of this protein on the host 
inflammatory response.  
 To better understand the role of SIRT1 and its role in disease, a working 
clone that expresses the SIRT1 protein is necessary. In this study, the human 
SIRT1 gene was amplified from commercially available template DNA using the 
Polymerase Chain Reaction (PCR). The SIRT1 gene was ligated into pET28b(+), 
a bacterial expression vector that works in Escherichia coli. The SIRT1 gene is 
expressed under control of the T7 promoter, which is not recognized by the 
transcriptional machinery in E.coli. Protein expression does not occur until a 
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source of T7 RNA polymerase is provided. Once obtained, the SIRT1-pET28b(+) 
plasmid was transferred into TOP10, a bacterial maintenance strain.  
 Once established, the SIRT1-pET28b(+) construct is transformed into an 
expression host containing a chromosomal copy of the T7 RNA polymerase 
gene. Induced by the addition of Isopropylthio-β-Galactoside (IPTG), the 
expression cell diverts almost all of its resources to express the target SIRT1 
gene. Overexpression of the SIRT1 protein allows for characterization of enzyme 
activity. Characterization of the mechanism where SIRT1 is inhibited by the 
native inhibitor nicotinamide (NAM) and the clinical antimycobacterial agent 
pyrazinamide (PZA) is needed.  
 The focus of this thesis is elucidation of the mechanism of inhibition of 
SIRT1. PZA, a clinical agent used to treat tuberculosis (TB), has been shown to 
allosterically inhibit SIRT1. It is of particular interest to determine where PZA, a 
NAM derivative, binds SIRT1 and if this binding can be included in natural 
regulatory network mechanisms within the cell. At the heart of this study, are 
attempts to understand the complex binding interactions of both PZA and 
pyrazinoic acid (POA), the chemotherapeutically active metabolite of PZA, in the 
presence of NAM. Competition experiments with these agents may prove useful 
to determine if these molecules interact at the same site, if the molecules can be 
displaced competitively, or if certain residues within parts of the enzyme are 
essential for characteristic binding. 
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INTRODUCTION 
Background Overview 
Pyrazinamide (PZA) is a nicotinamide analog with unique bactericidal 
action against TB (2). PZA is classified as a first-line anti-tuberculosis drug and is 
currently one of the best-tolerated therapies. The addition of PZA to the 
combined antitubercular regimen reduces treatment duration and thus led to 6-
month short course therapy (2). It has been hypothesized that PZA plays a 
critical role against semi-dormant bacilli in acidic intracellular environments (1). 
Curiously, PZA has been found relatively ineffective in axenic cultures implicating 
its specificity for targets endogenous to the diseased host. 
Despite the remarkable in vivo antimicrobial properties of PZA, the 
mechanism of action is not well understood (36). PZA likely functions as a pro-
drug, as it is known to undergo amide hydrolysis by mycobacterial 
pyrazinamidases (related to nicotinamidase) to pyrazinoic acid (POA), the 
putative chemotherapeutic agent (2). Recent studies have shown that treatment 
of Mtb-infected macrophages with (isoniazid) INH or PZA resulted in 
colocalization of the LC3 autophagosome and bacterial phagosome (19). This 
strongly suggests that antibiotic-induced autophagy targets bacteria to 
progressively more acidic compartments, and hence eventual lysosomal 
degradation (19).  
PZA treatment significantly induces the production of hydroxyl radicals 
and reactive oxygen species (ROS) in bacterial cells under slightly acidic 
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conditions (pH ≈6.0–6.5) (19). The observed upregulation of bacterial hydroxyl 
radicals may trigger autophagy leading to the acidification of bacterial 
phagosomes (phagosomal maturation) and hence be the origin of antimicrobial 
activity of PZA.  
These findings underscore the importance of chemotherapy on 
immunologic responses to mycobacterial infection (19).  Interestingly, PZA the 
clinical antitubercular agent has been shown to inhibit SIRT1 (private 
communication J. Seeley 2013). SIRT1 is a member of the Sirtuin family, a group 
of highly conserved histone deacetylases (HDAC) (18). SIRT1 is the closest 
mammalian ortholog of yeast SIR2, the founding member of this family of 
proteins (18). SIRT1 plays important regulatory roles in diverse cellular 
processes, including stress resistance, mitochondrial function, suppression of 
inflammation, and DNA repair (18). 
Conserved across species the SIR2-like gene was detected in Leishmania 
major and Leishmania infantum termed LiSIR2rp1 (L. infantum SIR2 related 
protein 1) (30). Immunological investigations indicate an immunoregulatory role 
for the protein. The capacity of LiSIR2rp1 to trigger B-cell effector functions 
during infection suggests this (30). These findings in addition to the interaction of 
LiSIR2rp1 with macrophages clearly demonstrates that this enzyme preforms a 
vital role in mediating the innate recognition of pathogens and orchestration of 
the acquired immune response to bacteria, viruses, and parasites (30). 
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The study of Sirtuins is a relatively new field, and although SIRT1 is the 
best defined member of the Sirtuin family, the discovery of the role of SIRT1 in 
the immune system has only emerged in recent years (20). SIRT1 has essential 
roles in the immune response (20) and the mechanism in which SIRT1 acts is 
vital to the characterization of its immunoregulatory function. Sirtuins share 
similar specificities for substrates indicating a conserved functional binding site 
for metabolites and biomolecules (12). Conserved interactions with substrates 
essential to the host immune response are characterized throughout this vast 
family of proteins. To understand the immunoregulatory role of SIRT1, it is 
important to understand how other sirtuins interact with these naturally selected 
substrates. 
 
Epigenetic Details  
Concerted efforts have been made to elucidate the mechanisms 
underlying chromatin dynamics and epigenetic modulation (3). Regional 
modifications of heterochromatin and structural alterations regulate gene 
silencing or expression (12). In yeast, the association of chromatin structure and 
transcriptional control is derived from two general areas of investigation - directed 
studies of Saccharomyces cerevisiae histone genes and transcriptional 
regulatory mutants (24). Mutant studies aided in the characterization of vital 
genes and accessory proteins. Identification of epigenetically relevant factors set 
the stage for the discovery of the Sir2 family, or sirtuins (3).   
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Initial Discovery of SIR Genes in Yeast 
The first sirtuin gene, SIR (Silent Information Regulator), was identified in 
S. cerevisae. The SIR gene initially went under the guise MAR1 (Mating-Type 
Regulator 1) and was characterized by virtue of a spontaneous mutation in the 
MAR1 gene causing sterility in mutants(22). In the unicellular eukaryote, mating 
type is regulated by a single genetic locus, the mating-type locus (MAT) (26). 
Two defined mating types are heritable via the expressed MATa or MATα alleles 
located near the center of chromosome III (16). This genetic locus governs 
sexual differentiation between in both haploid and diploid cells (16).  
Through a form of genetic recombination, haploid cells can switch 
between either the a or α mating type. Haploid yeast can frequently switch 
mating type with phenotypic differences arising from different sets of genes being 
transcribed or repressed. Mating-type recombination requires an additional set of 
genes, HMLα and HMRa (26). These genes are cryptic or repressed mating-type 
copies and act as reservoirs of mating-type information required for 
interconversion in haploid yeast cells (5). Transcriptional repression at these loci 
occurs despite the presence of functional promoters or structural genes (5). 
Transcriptional inactivation of the cryptic mating-type loci, known as silencing, 
occurs by the formation of a repressive chromatin structure (5).  
Relief of silencing at the mating-type loci HML and HMR and subsequent 
derepression of mating-type genes, results in a non-mating phenotype (22). 
Corroborating this report, Jasper Rine discovered a series of transcriptional 
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mutants that present a sterile phenotype (26). These mutations appeared in a 
family of SIR genes that when disrupted caused expression of the normally 
repressed mating-type genes (Figure 1). It was postulated that repression of the 
a and α genes at the silent loci stems from trans-acting regulators coded by 
these SIR genes (26). Therefore a set of four responsible genes SIR1-4 were 
identified and consequently, the MAR nomenclature replaced (22). 
 
Figure 1. Graphic Representation of Mating-Type Alleles in S. cerevisiae. 
The horizontal lines represents transcripts made from the two heritable MAT 
alleles, MATa and MATα. HML and HMR contain transcriptionally repressed 
copies of MATα (dotted in figure) and MATa (white in figure) respectively. HML 
and HMR loci serve as reservoirs of mating-type information necessary to mating 
type designation during haploid recombination. Transcriptional silencing of the 
HMLa and HMRα genes occurs by SIR gene products. Mutation of SIR genes 
causes derepression and thus expression of the silent mating cassettes, which is 
thought to cause sterility. Figure amended from (26). 
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SIR Genes Implicated in Other Regulatory Mechanisms 
 The SIR2 gene functions via a regulatory mechanism involved in mating-
type switching. Gottlieb and Esposito cited the prevalence of the wild-type SIR2 
gene in yeast and the role of this gene in depressing recombination in a 
ribosomal DNA (rDNA) tandem array (13). This study was the first to implicate 
SIR2 in suppression of recombination that indicated a role not specific to the 
mating-type system (13). 
 In eukaryotic chromosomes there are repeated genes families. In yeast, 
rDNA genes constitute as one such repeated family. It has been shown, that 
recombination events in repeated gene sequences occur at considerably lower 
frequencies in comparison with unique regions of DNA (10). In the absence of 
the SIR2 gene both mitotic and meiotic intrachromosomal exchange increases 
10- to 15-fold (13). 
 SIR2 is a prime constituent in a regulatory scheme that protects select 
repeated gene families from recombination in yeast (13). By suppressing 
recombinant events, SIR2 has been proposed to mediate chromosomal 
interconversion in rDNA by restriction of access to repeated sequences (13). It is 
clear that SIR2-dependent silencing is implicitly involved in gene expression 
affecting chromatin structure and genomic stability (3). 
 SIR2, SIR3, and SIR4 genes play an organizational role in regions of 
heterochromatin and formation of heterochromatin-like structures (4). Work by 
Gottschling and colleagues has provided compelling evidence that a basal level 
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of transcriptional repression also occurs at telomeres (4). Cytological 
observations in plants, insects, and mammals highlight the heterochromatic 
nature of telomeres (4).  
 The recognition that telomeres are crucial for the maintenance and 
replication of linear chromosomes is central to the understanding of telomeric 
construction and function of many eukaryotes (4). In addition to silencing the HM 
loci, SIR genes are essential modifiers acting to suppress transcription at 
telomeres in S. cerevisiae (4).  Single point mutations in histone H4 are sufficient 
to derepress telomeric position effects (4).  
 Interruptions in H3 and H4 amino acid sequences by integration of a 
known gene corresponds to a hyperacetylated or a transcriptionally active 
heterochromatin state (32). It was postulated that the H3 and H4 sequences 
must be maintained in order for full repression at yeast telomeres and at partially 
disabled silent mating loci (32). Studies by Thompson et al. were the first to 
suggest that acetylatable lysine residues on H3 and H4 histones played an 
important role by interacting with accessory silencing Sir proteins (32).  
 
Hypoacetylation of Histones and Transcriptional Silencing 
 By 1991, three classes of DNA sequences were known as targets of 
transcriptional inactivation: silent mating-type cassettes, the rDNA tandem array, 
and telomeres (8). Transcriptional silencing in yeast is region-specific, but 
sequence non-specific repression necessitated by chromatin remodeling (8). 
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Reports by Braunstein et al. associated the observed silencing with 
heterochromatic DNA packaging that displays distinct acetylation patterns (9).   
Closer examination of the nucleosome architecture highlights the 
importance of several highly conserved lysines.  The amino-terminal domains of 
all four histones harbor these conserved residues (9). It has been found that 
genes subject to long-term inactivation are tightly packaged in hypoacetylated 
nucleosomes (9). Genetic analysis of the hypoacetylated histone H4 in S. 
cerevisiae has been shown to preclude the silent cassettes from activating 
transcription (9). 
Regional silencing is a direct consequence of yeast histone H3 and H4 
posttranslational modification (32). Studies focused on the acetylation pattern of 
specific histone H4 lysine residues indicate deacetylation of lysine 16 as critically 
important (8). Mutant studies associate acetylation of K16 with the 
hyperexpressed X chromosome in male Drosophila, suggesting that the non-
acetylated state is required for effective gene repression (8, 9).  
The H3 and H4 acetylation sites have been reported to act synergistically 
to mediate the structurally repressed state (32). Thus, deacetylation patterns 
provide biochemical markers for identification of heterochromatic regions (9). 
Patterns of histone modulation and the accompanying affects on transcription are 
important in S. cerevisiae and, likely, in other eukaryotes (9).  
As an example, hypoacetylation of the core histones of Tetrahymena 
render micronuclei transcriptionally inactive (8). The importance of this finding 
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and in findings similarly observed across species is the correlation between 
transcriptional activity and the acetylation state of core histones. This set the 
stage for further study of epigenetic factors and relevant accessory proteins that 
regulate levels of transcription by altering the acetylation patterns of histones.   
 
Silencing Proteins Participate in Heterochromatin Formation 
Prior to the work of Braunstein et al., the mechanism by which histone 
modification mediates heterochromatic repression had not been established (32). 
Overexpression of Sir2, the SIR2 gene product, was reported to yield 
substantially reduced acetylation levels in three of the core histones (8, 9). Both 
the level of histone acetylation and the distribution of acetyl groups were 
diminished, underscoring the Sir2 dependence of this process (8, 9). Silenced 
regions of genomic material are strictly associated with the non-acetylated 
lysines of histones, indicating the likelihood that deacetylation is an essential 
component in the maintenance of the silent state (9). Overexpression of SIR2 led 
to significant histone deacetylation, distinguishing SIR2 from the other SIR genes 
(22).  
Although Sir2 and the induction of a hypoacetylated environment were 
related (8, 9), Sir2 is not totally responsible for silencing in yeast but is primarily 
involved in deacetylation of silent domains (9).  A multiple component system 
with interactions at specific sites in the nucleosome is likely involved (9). 
Braunstein et al. were the first to define the causal relationships underlying 
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silencing and to the elucidate central protein-protein interactions (9). Most 
specifically, these studies aimed at definition of the interaction between the 
nucleosome and components of the silencing apparatus (9).  
Sir2 acts to oppose the work of acetyltransferases, which modify enzymes 
by acetylating lysine (6). Counteracting the work of acetyltransferases, sirtuins 
deacetylate lysine regenerating the unmodified residue (6). The complementary 
action of acetyltransferases and deacetylases are centered in chromatin 
remodeling and the dynamic regulation of various biological processes (6). The 
conservation of structural homology of the Sir2 catalytic core led to the 
recognition that sirtuins are an instrumental family of histone deacetylases. 
 
SIR2 Demonstrated as a Member of a Large Ancient Family 
Identification of Sir2 orthologs in organisms ranging from bacteria to 
mammals illustrates the phylogenetic importance of this protein. Sir2 is the 
founding member of a large and well-conserved protein family of sirtuins. As 
rationale, sirtuins are notably for involved in gene silencing but also, cell cycle 
control, chromosome segregation, and double-strand DNA break (DSB) repair by 
way of a nonhomologous end-joining (NHEJ) mechanism (25).  
Initial phylogenetic analysis categorized 60 sirtuins into five main classes 
based on similarity to the seven human sirtuins (SIRT1-7)(25). More recent 
analyses have further classified 240 confirmed sirtuins with even more 
subdivisions (25). A cladogram incorporates data pertaining to similar aligned 
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sequences, experimentally determined substrate specificity, and cellular location 
to derive graphical outputs (25), providing a practical visualization and enabling 
interpretation of the functional relationships between members of this vast protein 
family.  
 The sirtuin family is classified by homology to the catalytic domain of the 
budding yeast factor Sir2 (3).  The Sir2 domain spans approximately 250 
residues (3). Despite the fact that every member of this ancient family shares 
catalytic similarities, the various members have evolved to serve a wide-range of 
functions with diverse specificities (Figure 2) (3). Variable amino- and carboxy- 
terminal extensions result in different localization patterns, regulation, and 
substrate selectivities (6).  
 For example, terminal variability of Hst2 in yeast results in restricted 
access to cellular compartments. Hst2 primarily resides in the cytoplasm due to a 
nuclear export signal present in its carboxy-terminal extension (6). This signal 
results in exclusion of Hst2 from the nucleus although this enzyme can shuttle 
into the nucleus to deacetylate histones (6). Conversely, four other yeast sirtuins 
are exclusively nuclear. Export signals in humans and in two Leishmania species 
are known, thus suggesting the importance of these termini and the influence of 
these sequences on protein specificity. Importantly, to draw parallels between 
proteins within this ancient family, it is imperative to identify the impact of these 
various sequences on protein function. 
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 The mammalian sirtuins are placed into four different classes (I-IV) (Figure 
3). Mammalian sirtuins 1, 2, and 3 belong to Class I which also is comprised of 
all yeast sirtuins as well as at least one of the Sir2-related proteins of eukaryotes 
(22). Class I is further subdivided into three sub-classes: a, b, and c (22). SIRT1 
shares Class Ia with Sir2 from S. cerevisiae, C. elegans, and D. melanogaster 
(22). SIRT4 is part of Class II that includes sirtuins from bacteria, insects, 
nematodes, and protozoa (22). Class III sirtuins is comprised of SIRT5 as well as 
a wide range of prokaryotes found in either bacteria or archaea (22). Class IV 
contains SIRT6 and SIRT7 and is inclusive of metazoans, plants, and vertebrates 
(22).  
 
 
Figure 3. Categorization of Sir2 Orthologs. The Class I Sir2 orthologs are of 
primary importance. Almost all yeast sirtuins are classified under this heading 
including human sirtuin 1, the closest homologue to Sir2 in S. cerevisiae. 
Interestingly, in this highly conserved family, Sir2 is closest to mammalian SIRT1. 
This not only indicates relative importance but also, opens up a larger discussion 
in terms of similarity of function, specificity, and overall mechanistic action 
between yeast and mammalian sirtuins. Figure amended from (22). 
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Prokaryotic Members with Unique NAD+ Dependent Activity 
 Remarkably, SIR2 genes are of phylogenetic significance in all eukaryotic 
organisms, prokaryotes, and archaea. In 2000, Imai reported the role of the first 
known Sir2 ortholog CobB, in Salmonella typhimurium, as an active component 
of a pyrimidine transfer reaction (17). CobB effectively modulates acetyl-CoA 
synthetase (ACS) via an NAD+-dependent deacetylation on lysine 609, which is 
an essential residue for catalysis (3, 7).  
 CobB also catalyzes the synthesis of N-(5-phospho-α-D-ribosyl)5,6-
dimethylbenzimidazole, a cobalamin biosynthetic intermediate (7). The 
intermediate was formed from nicotinate mononucleotide and 5,6-
dimethylbenzimidazole (7). CobB compliments a lack of 
phosphoribosyltransferase activity in CobT mutants (7). Mutants carrying 
deficiencies in CobT enzyme lose intrinsic pyridine nucleotide transferase 
functionality. However, the CobB protein appears to compensate for this loss of 
function (12), demonstrating that CobB protein is the primary of a pyridine 
nucleotide transferase process (12). 
 Computational analysis of the primary amino acid sequence of CobB 
identified consensus sequences with a high homology to conserved sequences 
characteristic of sirtuins (33). The discovery of CobB as a prokaryotic 
predecessor to the Sir2 family triggered consideration of the possibility of NAD+ 
as a necessary co-factor for deacetylase activity in yeast (17). Both CobB and 
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the eukaryotic Sir2 proteins were shown to possess ADP-ribosyltransferase 
activity where NAD+ is an essential co-substrate (31).  
 
Sir2 Proteins in Plasmodium 
Among Plasmodium species, P. falciparum is the etiologic agent 
responsible for the deadliest form of malaria (3). These intracellular parasites 
have a complex life cycle requiring passage through several stages requiring 
both a vector and a mammalian host (3). P. falciparum is known to harbor 
PfSIR2A (P. falciparum Sir2 protein), that has a high homology with the 
conserved core domain of Sir2 proteins of the Class III sirtuins (25).  
PfSIR2A mediates transcriptional silencing at subtelomeric regions, where 
an important multigene family involved in antigenic variation resides (25). This 
important multigene family, the var family, is comprised of 60-70 genes that 
encode the main surface adhesion factors expressed on parasite-infected 
erythrocytes (3). PfSIR2A utilization by parasites is required for control of gene 
expression by a switching mechanism, that enables expression of a given var 
gene at a given time (3).  
Evasion of the host immune system is the principle cause for Plasmodium 
virulence (25). PfSIR2A regulation of silencing associated var genes suggests 
the importance of the protein in malaria virulence (25). PfSIR2A exhibits both 
histone deacetylase and ADP-ribosyltransferase activity. Loss of these functions 
results in activation of many var genes (25). Expression of var genes permits the 
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establishment of the permissive chromatin state (25). Strains lacking expressed 
PfSIR2A have increased steady state RNA levels of 8-10 var genes with 
translation of at least one protein product (25).  
It is suggested that PfSIR2A silences var genes in a manner similar to the 
silencing of the mating-type genes in yeast (3). Even though not well understood, 
the silencing mechanism may be a potential chemotherapeutic target (3). Given 
the degree of conservation of the Sir2 family, the successful development of 
therapeutic remedies would necessitate that PfSIR2A be selectively inhibited and 
not the human sirtuins that share catalytic similarity (3). 
 
Sir2 Proteins in Trypanosoma 
Trypanosomes are unicellular flagellated parasites that are responsible for 
various human diseases (3). The Sir2 protein from Leishmania infantum, 
LiSIR2rp1, has been shown to influence the host immune system by inducing 
proliferation of activated B cells (25). The increased surface expression of CD40 
and CD86 may induce T cell activation and initiation of an adaptive immune 
response to infection (25).  
It appears that LiSIR2rp1 may act at multiple points in the immune 
response as LiSIR2rp1 can also induce maturation of dendritic cells (DCs) and 
activate macrophages (25). LiSIR2rp1 acts on B cells and DCs via Toll-like 
receptor 2 (TLR2) both in vitro and in vivo often, macrophage activation is TLR2-
independent (25). Leishmania lipophosphoglycans and GPI-anchored proteins 
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may stimulate signaling pathways by binding to TLR2 and thereby indirectly 
activating macrophages and natural killer (NK) cells (25).  
In addition to activating the host immune response, LiSIR2rp1 has been 
implicated in resistance to apoptosis and promotion of cell viability (3). LiSIR2rp1 
has both NAD+-dependent deacetylase activity and ADP-ribosyltransferase 
activity (25). Over-expression of LiSIR2rp1 in different Leishmania species 
significantly delays apoptosis mediated cell death at different parasite stages (3). 
Interestingly, yeast Sir2 was the first reported sirtuin that caused lifespan 
extension (11). Overexpression of Sir2 via insertion of a duplicate copy of the 
SIR2 gene in the yeast genome resulted in a lifespan increase 30% greater than 
that of the wild-type control (11).  Similar effects have been found in worms and 
flies, thus suggesting the ubiquity of these genes and effects of the respective 
protein products on cellular longevity (11).  
 
SIRT1 and Cellular Localization 
 Mammals harbor seven members of the Sir2 family, SIRT1-7 (14). SIRT1 
is the best characterized of the mammalian sirtuins as it shares the highest 
homology with the progenitor protein Sir2 (35). Undeniably, SIRT1 shares 
catalytic likeness to Sir2 however, the correlation between historic findings in 
yeast and mammalian SIRT1 specificity and function needs to be considered. 
 As mentioned earlier, sirtuins exhibit a diverse pattern of localization. 
SIRT1 is highly promiscuous and known to shuttle between cellular 
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compartments (34). Although largely found in the nucleus, in certain cell types, it 
can be found in the cytoplasm (3). For instance, in rat cardiomyocytes, SIRT1 
localizes to the nucleus in the embryo, the cytoplasm in newborns, and to both 
the nucleus and the cytoplasm in adults (3). SIRT1 displays a disparate 
localization pattern that is observed across eukaryotes. In the human embryonic 
kidney cell lines, SIRT1 is present in the nucleolus whereas in other cell lines the 
protein is either absent or present in only discrete amounts (3).  
 Although largely conserved, there are differences in the amino and 
carboxy termini of SIRT1 that flank the catalytic core (29). These differences 
result in various interaction motifs and cellular localization signals observed 
across the various mammalian sirtuins (Figure 4) (29).  
 
 
 
Figure 4. Comparison of Sir2 and SIRT1. This graphic shows the primary 
structures of Sir2 in yeast and SIRT1 in humans. Both share a unique catalytic 
core domain and the highly conserved GAGxSsssG sequence diagnostic for 
sirtuins. The asterisk is representative of a histidine mutation that once present 
will abolish enzymatic activity of these two proteins. It is important to note that 
SIRT1 has larger unordered regions at NH2- and COOH- termini. Figure take 
from (34). 
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It is likely that these divergent biological functions impact enzymatic activity, 
binding specificity, and subcellular localization and expression patterns (29). 
Relative cellular locations of each member of the mammalian sirtuins are 
illustrated in Figure 5.  
 
SIRT1 Function 
 Although sirtuins were originally identified as HDACs, sirtuins are known 
to modify many non-histone proteins. In addition to posttranslational modification 
of substrates responsible for gene silencing, cell cycle regulation, cell 
metabolism, apoptosis, tumourigenesis, and regulation of lifespan are also 
influenced (15). The unique NAD+ dependence of sirtuin action is a prime target 
for therapeutic intervention.  
 CobB was the first sirtuin member to implicate the novel NAD+-dependent 
chemistry (6). In contrast with other HDAC classes, that do not require cofactors 
for activity, sirtuins catalyze the hydrolysis of the acetyl group on lysine side 
chains consuming NAD+ in the process (6).  
Intriguingly, studies of yeast Sir2 resulted in a 23-27% deacetylation of 
conserved lysines in the presence of NAD+ (17). Successive experiments with 
NADH, NADP, and NADPH did not significantly increase deacetylation levels as 
was observed on introduction of NAD+ (17). Consequently it was concluded, that 
Sir2 is an NAD+-dependent histone deacetylase (17). Experiments demonstrated 
that the molar ratio of deacetylated peptide to Sir2 was in excess, implicating Sir2 
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as the catalyst for multiple reaction cycles (17). Curiously, this is the first example 
described in eukaryotes where NAD+ drives a distinct enzymatic reaction (17).  
 SIRT1 shares this same catalytic core and deacetylates lysines in a novel 
reaction that also consumes NAD+, releasing nicotinamide and O-acetyl-ADP-
ribose (OAADPR) (17) (Figure 6).  
 
NAD+ 
POA PZA NAM 
2’ OAADPR 3’ OAADPR  
 
Figure 6. Cofactors, Inhibitors, and Byproducts of SIRT1. NAD+ is a 
necessary cofactor for sirtuin deacetylase activity and 2’-O-acetyl-ADP-ribose 
(OAADPR) and NAM are byproducts of the deacetylation reaction. 2’OAADPR 
equilibrates to a mixture of 2’- and 3’-OAADPR by way of an intramolecular 
transesterification. PZA is an inhibitor of SIRT1 with unique structural similarities 
to NAM, a natural noncompetitive inhibitor. PZA undergoes amide hydrolysis by 
nicotinamidases within the cell producing pyrazinoic acid (POA), the putative 
active derivative. It is hypothesized that treatment with PZA causes an 
accumulation of POA within cells. POA has been shown to bind SIRT6, a human 
homologue of Sir2, at a much higher affinity than PZA. It is of interest to see if 
this phenomenon can be observed in SIRT1 and if binding influences modulation 
of key proteins implicit in the host immune response during cytotoxic stress and 
inflammation.  
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 Crystallographic structures of nine different sirtuins from archaea, 
bacteria, and eukaryotes confirm that the homologous catalytic core is divided 
into two characteristic subdomains (6). The larger domain adopts a canonical 
Rossmann fold, a mononucleotide binding motif that has been shown to bind a 
variety of cellular metabolites including NAD+/NADH or NADP+/NADPH (6). The 
smaller domain arises from two insertions in the Rossmann fold, and consists of 
a zinc-binding module (6). The zinc is coordinated by four conserved cysteine 
residues that appear to play a structural role (6).  
 SIRT1 catalyzes the cleavage of the glycosidic bond between 
nicotinamide and ADP-ribose of NAD+ (29). The acetyl residue from the formerly 
acetylated lysine-peptide is transferred to ADP ribose, releasing nicotinamide, 
deacetylated peptide, and a mixture of 2’- and 3’-O-acetyl-ADP-ribose 
(OAADPR) (29). The mechanism of SIRT1 mediated acetyl cleavage follows 
accordingly: the first step is the concerted attack of acetyl lysine at the 1’-carbon 
of the nicotinamide ribose, displacing the nicotinamide in an SN2-like reaction 
yielding an O-alkylamidate species (29). The 2’ hydroxyl of the O-alkylamidate is 
activated by an adjacent histidine residue and subsequently, an intramolecular 
nucleophilic attack ensues. Nucleophilic attack on the O-alkylamidate leads to 
formation of a dioxolane. Cleavage from the deacetylated peptide yields a 1’, 2’-
cyclic intermediate. Addition of a water molecule furnishes 2’OAADPR that 
equilibrates to a mixture of 2’- and 3’-OAADPR by way of an intramolecular 
transesterification (Figure 7). 
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Figure 7. Sirtuin Deacetylation Reaction. An acetylated lysine (K) residue of a 
histone protein is a sirtuin substrate. Nicotinamide adenine dinucleotide and 
water are necessary for the reaction. Figure amended (29). 
 
NAD+ as a Cofactor and NAD+ Derivatives as Therapeutic Agents 
 A number of studies have indicated a correlation between transcription 
levels and the bioavailability of nutrients. Sirtuins are proposed to act through 
nutrient sensing. Studies of Sir2 mechanistic actions have improved the 
understanding of sirtuin function in humans (23), specifically the role of histone 
deacetylation in NAD+ breakdown (23). However, a detailed mechanistic 
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description of the function of Sir2 and sirtuins in metabolic regulation and stress 
resistance remains to be elucidated (23).  
 Disease-related proteins are known to be targeted for deacetylation by 
sirtuins (21). Concerted efforts have been made to identify and characterize 
small molecule agonists and antagonists that can be used as research tools and 
therapeutic agents (21). There are several classes of direct sirtuin inhibitors 
including nicotinamide (NAM), splitomycin, and sirtinol (21). Sirtuin agonists, 
STACs (sirtuin activating compounds), have been found to activate the human 
SIRT1 enzyme by increasing the binding affinity of the acetylated target protein 
(21). Known STACs include the red wine compound resveratrol and other 
polyphenol compounds (21). 
 Intriguingly, PZA, the clinical antitubercular agent has been shown to 
inhibit SIRT1 (private communication J. Seeley 2013). PZA is a nicotinamide 
analog with unique bactericidal action and currently one of the best-tolerated 
antitubercular therapies. PZA is relatively ineffective in axenic cultures implicating 
targets endogenous to the diseased host. This suggests PZA, and its putative 
active derivative POA, as agents that can influence host orchestrating 
immunologic response. It is therefore of interest to determine how PZA, a known 
inhibitor of SIRT1, influences the sirtuin modulation of primary proteins in the 
host immune response.  
 
 
 25 
SIRT1 Immunologic Targets 
 Similar to yeast Sir2, mammalian SIRT1 necessitates heterochromatin 
formation by induced hypoacetylation, which effectively silences transcription. 
Silencing transcription of inflammation related genes is critically important in host 
responses to infection and disease. SIRT1 targets the deacetylatation of lysines 
at positions 9 and 26 of histone H1, 14 of H3, and 16 of H4 (22). Various non-
histone targets have also been confirmed. Reported interactions with p53, BCL6, 
TAFI68, CTIP2, and NF-κB (Figure 8) are among the many substrates upon 
which SIRT1 acts. Modulation of these non-histone substrates dramatically 
influences the level of transcription and profoundly influences cell signaling 
during cytotoxic stress. 
 
Figure 7. Cellular Functions of Mammalian Sirtuins. Sirtuins are implicated in 
a variety of processes in mammalian cells. SIRT1 modulates not only chromatin 
structure but also gene expression by targeting lysines on p300, Tat, PML, and 
p53 protecting cells from senescence. Figure taken from (22).  
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p53 Interaction 
 p53 functions as a tumor suppressor and is subject to a variety of 
posttranslational modifications that modulate the suppressor activity. DNA 
damage induces p300 acetyltransferase causing acetylation of p53 resulting in 
activation (7). SIRT1 and p53 are known to form a complex regulate enzymatic 
action (22). SIRT1 deacetylates several lysine residues on p53 in mouse models 
and induces hypoacetylation at Lys320, Lys373, and Lys382 of human p53 (22). 
SIRT1-dependent deacetylation of p53 inhibits transactivation activity and 
moderates apoptosis in response to oxidative stress and DNA damage (22). 
Interestingly, NAD+ is a requirement for the deacetylation reaction (7). Increased 
levels of p53 acetylation were shown in human fibroblasts exposed to ionizing 
radiation (7). Fibroblasts that overexpress the SIRT1 protein were shown to 
abrogate the hyperacetylated state, indicating yet another circumstance in which 
SIRT1 induces the hypoacetylated chromatin state (7).  The SIRT1-dependent 
hypoacetylated state predominated due to oxidative stress and DNA damage, 
which indicates SIRT1 and its putative role in stress resistance (7).  
 p53 is implicit in progression of an inflammatory response (35). A key 
player in cellular signaling and stress response, p53 is essential to the host 
response to infection.  Enhanced by acetylation of Lys382, a primary target of 
SIRT1, can reversibly be deactivated by deacetylation (35). SIRT1 is likely a   
mediator of p53 and potentially a modulator of the host immune response to 
cellular injury. Thus, SIRT1 might alleviate the cytotoxic effects of a strong 
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immune response during inflammation or infection via its novel deacetylase 
activity (Figure 9).  
 
Figure 9. Targets of SIRT1 in the Inflammatory Pathway. Acetylation of 
histone tails plays an imperative role in activation of gene transcription. 
Reversibly, deacetylation by SIRT1 may result in structural reorganization and 
the formation of silent chromatin domains much like Sir2 activity in yeast. It is 
known that acetylation of nuclear factor-kappa B (NF-κB) p65 is necessary for full 
activation.  SIRT1 is shown to physically associated with NF-κB and silence 
transcription by deacetylation of p65. SIRT1 targets AP-1 and inhibits 
transcriptional activity of AP-1. Modification of p53 via SIRT1 deacetylation is key 
in inhibiting inflammation related gene expression. Figure taken from (35). 
 
Relationship Between p53, NF-κB, and SIRT1 
 Transcriptional factors and acetyltransferases are involved in complex 
interactions that mediate inflammatory gene expression (35). The 
pathophysiological significance of these acetylation and deacetylation patterns to 
the inflammatory response is not known (35).  Sirtuins are ubiquitously 
expressed and their properties as survival and stress resistance factors maps 
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well onto the function and effects of NF-κB signaling (27). The NF-κB system 
belongs to a pleiotropic transcription factor family well known in inflammation 
(29). NF-κB has been identified as one of the master regulators of both adaptive 
and innate immunity (29). NF-κB is targeted for regulation via acetylation and 
deacetylation by histone deacetylases like SIRT1 (29).  
Recent findings have shown that ROS and oxidative stress can activate 
the NF-κB signaling by pro-inflammatory cytokines such as IL-1β (Interleukin-1β), 
TNF-α (Tumor Necrosis Factor-α), and TLRs (27). Curiously, ROS and 
inflammatory agents are thought to trigger initiation of autophagy leading to the 
acidification of bacterial phagosomes, one of the putative antimicrobial effects of 
PZA on treatment of Mtb infection (19). It is suggested that ROS generation is 
central to drug therapy during TB infection (19). These findings underscore the 
importance of a successful immunologic response to infectious agents during the 
course of chemotherapy (19). 
It is clear that as a key regulator in host immune response, SIRT1 
influences regulation of critical factors and essential proteins. PZA, a known 
SIRT1 inhibitor, is one of the best- tolerated antitubercular therapies. PZA and 
POA maybe critical to mounting an effective immune response to mycobacterial 
infection. The specific aim set forth in this study is to characterize the binding of 
PZA and POA to SIRT1 to assess the plausibility that these agents effectively 
inhibit SIRT1 and stimulated the host immune response to infection and disease. 
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SPECIFIC AIMS 
Primary Goal  
 The goal of this study is to determine the mechanism of action of PZA and 
PZA analogs in SIRT1 inhibition and how this inhibition effects SIRT1-dependent 
deacetylation of substrates involved in immune response. 
  
Expression 
 Expression of the SIRT1 protein is central to the purposed research; 
therefore the immediate focus is cloning the SIRT1 gene into a bacterial vector. 
The gene will be hosted in a bacterial maintenance strain where the plasmid can 
be amplified and transformed into a protein expression system. Upon induction, 
the expression system will generate SIRT1 protein in quantities sufficient for the 
investigation of enzymatic activity. Activity of experimentally obtained protein will 
be compared to commercially available SIRT1 to assess enzyme functionality. 
 
Competition Studies 
 SIRT1 is an NAD+ dependent deacetylase with NAD+ a cofactor. NAM, a 
byproduct of the reaction, is a natural inhibitor of this enzyme. NAM is also a 
central element in a variety of cellular processes, suggesting that SIRT1 maybe 
modulated by cellular metabolism. An intermediate goal of this project is 
assessment of SIRT1 inhibition by therapeutic agents in the presence of native 
inhibitors.  
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Characterization of SIRT1 Action in Immune Response 
 PZA, an antitubercular agent, has been shown to bind an allosteric site on 
the SIRT1 protein. It is of interest to determine how this compound, effective in  
disease treatment, binds SIRT1 and how PZA influences host immune 
responses. The long-term goal of this project is an investigation of the effect of 
SIRT1 inhibition on the host immune response.  
 PZA, an effective agent for TB treatment is administered early in the 
course of infection, but the mechanism of action is only poorly understood. The 
accumulation of POA, the active derivative of PZA, aids in the sequestration of 
the Mycobacterium tuberculosis into compartments destined for lysosomal 
degradation. As a component of one of the best-tolerated therapies, PZA may act 
as a pro drug for POA, which is hypothesized to interact with cellular components 
during infection. Since most therapeutic agents that inhibit SIRT1 have been 
shown to be toxic to the cell, once characterized, inhibition of SIRT1 by the PZA 
class of inhibitors could work as a curative measure in treating infection. 
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METHODS 
 
Expression of SIRT1 Using pCMVSPORT6 
  HsCD00331342, the cDNA clone deposited into the PlasmID database at 
Harvard Medical School, was used in this study. The construct includes the 
human SIRT1 cDNA in the pCMVSPORT6 vector (Invitrogen). The plasmid 
containing ampicillin resistance for selection purposes is hosted in a DH5α 
bacterial maintenance strain. The cells harboring the plasmid of interest were 
plated and grown on 100 µg/mL Ampicillin plates and amplified using LB broth 
purchased from Fisher BioReagents (Figure 10).  The broth is treated with 100 
µg/mL of ampicillin prior to inoculation maintaining to select for cells with 
resistance selection imparted by the pCMVSPORT6 vector. Several 10 mL 
cultures are prepared for overnight growth. 
 
Figure 10. Outline of Methods. The flow chart outlines the original intentions set 
forth by this project. The host DH5α cells harboring the SIRT1-pCMVSPORT6 
was amplified, extracted, double digested for confirmation, and sent for 
sequencing. The extracted plasmid was transformed into BL21DE3 expression 
cells and attempts were made to express SIRT1 protein. 
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 Cultures were incubated for 12-16 hrs with vigorous shaking (200 RPM) at 
37 °C. Cultures that appeared cloudy after the designated incubation period and 
were centrifuged at 4000 RPM for 20 minutes at 4 °C to obtain a small brown 
pellet. Glycerol stocks were prepared according to the literature (28). DNA was 
isolated using the QIAprep Spin Miniprep Kit (Qiagen Inc., Valencia, CA). It was 
useful to centrifuge the sample twice after addition of PE buffer as residual 
ethanol remaining on the column resulted in a lower plasmid yield. The optional 
PB buffer step was also used in the plasmid extraction protocol. The DNA 
concentration was measured using the ND-1000 Spectrophotometer to 
determine the concentration of plasmid generated in ng/µL.  
 Prior to sequencing, double digestion was employed to determine if DNA 
fragments of the expected size were recovered. This approach can confirm that 
the extracted DNA was in fact the plasmid of interest. Double digestion was 
effectual using 1µL of the concentrated DNA, which was subsequently diluted 
further to a concentration appropriate for restriction endonuclease digestion 
(Figure 11). The SIRT1-pCMVSPORT6 plasmid was digested by Kpn1 and 
EcoR1 restriction enzymes (New England BioLabs) and digested products 
separated on a 0.75% agarose gel. Fragments were visualized by gel staining 
with 40 µL of ethidium bromide and a Bio-Rad Imager. On confirmation of the 
presence of the desired fragments, the extracted plasmid was sent for 
sequencing.  
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 The sequencing data was compared to the known SIRT1 insert sequence 
to establish if the experimentally amplified plasmid had a high homology to the 
known SIRT1 sequence provided by the PlasmID database. Samples with high 
sequence homology were transformed into chemically competent cells.  
 BL21®DE3™ cells (Invitrogen) were used for transformation experiments. 
Standard transformation protocols outlined in the literature were used. The 
transformation reaction mixture was plated on 100 µg/mL Ampicillin plates and 
incubated overnight. Individual colonies were selected and used to inoculate 1 
mL of LB broth treated with 100 µg/mL Ampicillin. The culture was grown for 6 
hours or until cloudy and added to an Erlenmeyer flask containing 49 mL of 
antibiotic treated LB media. The total reaction volume was 50 mL. The culture 
was grown to mid-log phase or to an OD600 of approximately 0.6 to 0.9. Upon 
reaching the optimum optical density, the mixture was induced with isopropylthio-
β-galactoside (IPTG) to induced expression at the T7 promoter. The T7 promoter 
flanks the SIRT1 gene and controls the expression levels. IPTG binds to 
inducible elements upstream of the promoter region and causes the translation 
required for exploitation of the host bacterial machinery. Pellets were obtained 
every 2-4 hours during induced expression. Samples were visualized by standard 
10 % sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE). 
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Cloning Methods  
 The initial outline of methods was reconsidered and a new plan was 
drafted once expression experiments proved unfruitful. The new focus is cloning 
the SIRT1 gene into a bacterial vector. The following is a brief outline of the 
cloning methods employed (Figure 12). 
 
 
Figure 12. Outline of Cloning Methods. The flow chart outlines the sequence 
of experiments needed to successfully clone the human SIRT1 gene into a 
bacterial vector. The first step was to PCR amplify the SIRT1 gene from the 
SIRT1-pCMVSPORT6 template adding restriction ends that could cleave both 
the insert and the vector and yield appropriate sticky ends. The insert and vector 
fragments would then be ligated together, transformed into a maintenance strain 
and amplified. The plasmid would then successively be extracted and double 
digested with the same enzymes used to construct the plasmid. This would result 
in the same size DNA fragments. The clone would then be transformed into an 
expression cell and used to express the SIRT1 protein. 
 
 The SIRT1-pCMVSPORT6 clone HsCD00331342 was amplified and 
served as the template for the following cloning procedures. The 3,691bp SIRT1 
PCR Amplification of SIRT1 
Double Digestion 
Ligation 
Transformation 
Plasmid Extraction 
Double Digestion of Plasmid 
to Confirm 
Transform Plasmid Into an 
Expression Cell  
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insert as analyzed in Clone Manager was shown to include many non-protein 
coding regions within the insert. It was proposed to sequester the protein-coding 
region of the insert using standard PCR methods (Figure 13). Short 
oligonucleotide sequences approximately twenty base pairs in length were 
designed explicitly to flank the SIRT1 coding region. The synthesized primers 
hybridize to the template DNA coding for SIRT1. The primers serve as an 
initiation point for DNA synthesis and the SIRT1 DNA is subsequently copied by 
the polymerase. Addition of restriction sites within the oligonucleotide primers 
was necessary for ligation of the SIRT1 gene into pET-28b(+) bacterial vector 
(Novagen. Inc., Madison, WI).  
 
Figure 13. Development of the PCR Strategy. SIRT1 is a 747 amino acid 
protein with its active site being the deacetylase domain.  The deacetylase 
domain is 208 amino acids and corresponds to base pairs 768-1392 in the insert 
sequence provided by the PlasmID database. The idea was to target the entire 
protein-coding region for PCR without adding extraneous amino acids or 
removing them. Thus, SIRT1 could be expressed from the construct prepared.  
 
 The first consideration was the identification of unique restriction sites 
present at the Multiple Cloning Site (MCS) of the pET28b(+) bacterial vector 
(Figure 14). Importantly, the SIRT1 insert fragment needed to be in frame with 
the 6xHis Tag present of the vector, the hexahistidine tract appended to the 
translated protein product for easy purification via metal ion affinity 
Our Gene of Interest 
This is the region of the Sirt1 gene that contains the protein 
code for the active site of our enzyme. Our rationale, was to 
PCR amplify the Sirt1 gene using primers that add Nde1 and 
Eag1 restriction sites to the front and back ends of the PCR 
product respectively. 
 
768 BP 1392 BP 
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chromatography. A number of unique restriction sites were identified and then 
compared to see if resulting sticky ends were capable of false pairing. Forward 
and reverse primers were designed. The forward primer includes an Nde1 
restriction site and the reverse primer includes an Eag1 restriction site. These 
primers were used to amplify SIRT1 DNA from the SIRT1-pCMVSPORT6 
template DNA.  
 
Figure 14. Unique Restriction Sites in pET-28b(+). The following is a map 
provided by Novagen that indicates the key features of this bacterial vector. The 
maps for pET-28b(+) and pET-28c(+) are identical to the above map with the 
following exceptions: pET-28b(+) is a 5,368bp plasmid; subtract 1bp from each 
site beyond BamH I at 198 to shift the reading frame. pET-28c(+) is a 5,367bp 
plasmid; subtract 2bp from each site beyond BamH I at 198. This vector has 
Kanamycin sulfate resistance, which was used for selection. 
Novagen • ORDERING 800-526-7319 • TECHNICAL SUPPORT 800-207-0144
Bgl II
Nhe I
Xba Ilac operator
pET upstream primer #69214-3
T7 promoter primer #69348-3
T7 promoter rbs
Bpu1102 I
T7 terminator primer #69337-3
T7 terminator
T7•TagHis•Tag
thrombin
Nde I
His•TagHind IIIEcoR I Xho IBamH I Sac I Not I
Nco I
Eag I
Sal I
pET-28a-c(+) cloning/expression region
TB074  12/98
The pET-28a-c(+) vectors carry an N-terminal His•Tag®/thrombin/T7•Tag® configuration plus
an optional C-terminal His•Tag sequence. Unique sites are shown on the circle map. Note that the
sequence is numbered by the pBR322 convention, so the T7 expression region is reversed on the
circular map. The cloning/expression region of the coding strand transcribed by T7 RNA poly-
merase is shown below. The f1 origin is oriented so that infection with helper phage will produce
virions containing single-stranded DNA that corresponds to e coding strand. Therefore, single-
stranded sequencing should be performed using the T7 terminator primer (Cat. No. 69337-3).
pET-28a(+) sequence landmarks
T7 promoter 370-386
T7 transcription start 369
His•Tag coding sequence 270-287
T7•Tag coding sequence 207-239
Multiple cloning sites
(BamH I - Xho I) 158-203
His•Tag coding sequence 140-157
T7 terminator 26-72
lacI coding sequence 773-1852
pBR322 origin 3286
Kan coding sequence 3995-4807
f1 origin 4903-5358
The maps for pET-28b(+) and pET-28c(+)
are the same as pET-28a(+) (shown) with
the following exceptions: pET-28b(+) is a
5368bp plasmid; subtract 1bp from each site
beyond BamH I at 198. pET-28c(+) is a
5367bp plasmid; subtract 2bp from each site
beyond BamH I at 198. 
pET-28a-c(+) Vectors
lacI (773-1852)
ori (3286)
Ka
n (
39
95
-48
07
)
f1 o
rigin 
(4903-5358)
Bpu1102 I(80)
Xba I(335)
Bgl II(401)
SgrA I(442)
Sph I(598)
Mlu I(1123)
Bcl I(1137)
BstE II(1304)
Apa I(1334)
BssH II(1534)
EcoR V(1573)
Hpa I(1629)
PshA I(1968)
Bgl I(2187)
Fsp I(2205)
Psp5 II(2230)
Tth111 I(2969)
Bst1107 I(2995)
Sap I(3108)
BspLU11 I(3224)
BssS I(3397)
AlwN I(3640)
Eco57 I(3772)
Nru I(4083)
Cla I(4117)
Sma I(4300)
Pvu I(4426)
Sgf I(4426)
Dra III(5127)
Xho I(158)
Not I(166)
Eag I(166)
Hind III(173)
Sal I(179)
Sac I(190)
EcoR I(192)
BamH I(198)
Nhe I(231)
Nde I(238)
Nco I(296)
pET-28a(+)
(5369bp)
Cat. No.
pET-28a DNA 69864-3
pET-28b DNA 69865-3
pET-28c DNA 69866-3
71 base pairs 
removed 
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 The forward primer was designed so that the Nde1 restriction site 
precedes the start codon with addition of a single thymine prior to the methionine 
(ATG) start codon. For the reverse primer, the Eag1 restriction site is 12 base 
pairs subsequent to the stop codon (TAG). Primers were designed according to 
New England BioLabs specifications. The restriction enzymes were purchased 
through the same company and were employed to make the designated cut 
sites.  
 
Design of Primers For PCR 
 The following are the forward and reverse primers that were developed to 
PCR amplify the SIRT1 gene from the SIRT1-pCMVSPORT6 template.  
 
Forward Primer:    5’ AAA CGG CCG CAC TAT GAT TTG TTT GAT GGA TAG 3’ 
 
Reverse Primer:    5’ TAT TTC ATC ATA TGA TTG GCA CAG ATC CTC 3’ 
 
 The above primers have melting temperatures (Tm) of 56.8°C and 62.0°C 
respectively. As the annealing temperature is directly influenced by primer length 
and nucleotide composition, the PCR was optimized using an annealing 
temperature of 50 °C. Both Phusion® High-Fidelity DNA Polymerase (New 
England BioLabs) and Taq Polymerase were used in parallel experiments. PCR 
utilizing Phusion® was the most reproducible (Figure 15). The following reagents 
were used accordingly: 10 µL of 5X Phusion HF Buffer (New England BioLabs), 1 
µL of 2.5 mM dNTP Mix (New England BioLabs), 12.5 µL of the prepared primer 
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mix, 0.5 µL of Phusion enzyme, 0.5 µL diluted SIRT1-pCMVSPORT6 template, 
25.5 µL of nuclease-free water.  
 
 
Figure 15. Schematic of the PCR Reaction. SIRT1 is PCR amplified using a 
forward primer containing and Nde1 restriction site and a reverse primer 
containing an Eag1 restriction site. 
 
 The primer mix contained the following ingredients, 10 µL of Nde1 forward 
primer, 10 µL of Eag1 reverse primer, and 480 µL of water. The SIRT1-
pCMVSPORT6 plasmid extracted using the Qiagen Miniprep protocols had high 
concentrations and it was pertinent to dilute the template 200 fold for optimal 
PCR results. The following were the standard settings using a Veriti 96 Well 
Thermal Cycler by Applied Biosystems (Figure 16). 
 
 
1000 3000 2000 
SIRT1 
pCMV!Sport6 
Eag1 
Nde1 
PCR product 
Eag1 Nde1 
1.6 kbp 
Polymerase Chain Reaction 
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95.0 95.0 
50.0 
72.0 72.0 
4.0 
1:00 0:30 
1:00 
3:00 5:00 
∞ 
Step 1 Step 1 Step 2 Step 3 Step 1 Step 2 
Stage 1 
1 
Stage 2 
30 
Stage 3 
1 x x x
 
 
Figure 16. Thermal Cycler Settings. Above are the optimized conditions used 
to achieve the expected 1.6 kbp SIRT1 PCR product. Stage 1 heats the reaction 
mixture to 95 °C for 1 minute, denaturing the DNA template. In Stage 2, the 
reaction mixture was preset for 95°C for 30 seconds and then the temperature 
lowered to the optimal Tm for both primers. Primer annealing occurs at 50 °C for 1 
minute. Primer elongation phase was set to the standard 72 °C for 3 minutes. 
Primer annealing and elongation was repeated for 30 cycles. Following 
elongation, the reaction mixture was kept at 72 °C for 5 minutes and then cooled 
to 4 °C thus, completing the PCR amplification.  
 
 To determine appropriate DNA concentration required for digestion and 
ligation, 16 PCR reactions were prepared.  All reactions were directly applied to a 
single QIAquick Gel Extraction column (Qiagen Inc., Valencia, CA). The PCR 
cleanup protocol employing the buffer PB retained greater concentrations of our 
SIRT1 PCR product without significant product loss in flow through. After the PE 
wash step, the column was warmed on a heating block at 65 °C for 5 minutes to 
remove residual ethanol. The column was then treated with 30 µL of buffer EB to 
elute the DNA from the column. Approximately 5 minutes after adding the elution 
buffer, the column was centrifuged to yield the purified SIRT1 PCR product. 
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Double Digestion with Eag1 and Nde1 
 PCR-amplified product was placed on ice prior to double digestion. Buffers 
and enzymes were purchased from New England Biolabs. Both Nde1 and Eag1 
are compatible in NEBuffer 3. Nde1 is reported to have 75% efficiency in 
NEBuffer 3 however, comparative analysis of digested products with the 
undigested controls established the utility of this buffer in these experiments. 
Over the course of study, maximizing the efficacy of each step in the cloning 
procedure was imperative. The following are the optimal reaction volumes 
employed (Table 1 and Table 2): 
 
Table 1. Double Digestion Reaction 1.  Double digestion reactions were 
prepared for both the insert and vector. The pET28b(+) vector is highly 
concentrated in comparison to the insert so the vector was diluted by addition of 
water.  
 
 
 
 
 
 
 
 
 
 
Reagents Added 
(Reaction 2) 
Volumes Used in Insert 
Digestion Mixture (µL) 
Volumes Used in Vector 
Digestion Mixture (µL)  
Water 10 30 
DNA 30 10 
BSA 0.5 0.5 
NEBuffer 3 5.0 5.0 
NdeI 2.5 2.5 
EagI 2.0 2.0 
Reagents Added 
(Reaction 1) 
Volumes Used in Insert 
Digestion Mixture (µL) 
Volumes Used in Vector 
Digestion Mixture (µL) 
Water - 35 
DNA 40 5.0 
BSA 0.5  0.5 
NEBuffer 3 5.0  5.0 
NdeI 2.5 2.5 
EagI 2.0  2.0 
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Table 2. Double Digestion Reaction 2.  Double digestion reactions were 
prepared for both the insert and vector. In this case, the vector was not diluted 
because the PCR-amplified product was highly concentrated.  
 
 
 The 50 µL reaction mixtures were gently mixed, then incubated for 2 hours 
at 37 °C. Samples were analyzed on a 0.75 % agarose gel. The loaded samples 
contained a 5:1 (reaction volume: 6x Loading buffer) volume ratio. The agarose 
gel was stained with 40 µL of ethidium bromide and was developed for 30 
minutes. Bands were visualized using a Bio-rad Imager and excised using a 
clean scalpel. Insert (Figure 17) and vector (Figure 18) gel slices were placed in 
a pre-weighed microcentrifuge tube. Weights of the gel slices were found by 
difference. Standard Qiagen gel extraction protocols were followed. 
 
 
 
 
 
 
 
 
 
Figure 17. Introduced Restriction Sites on SIRT1. Nde1 and Eag1 restriction 
endonucleases make the appropriate cuts along the front and back ends of the 
PCR amplified SIRT1 product respectively. 
Agarose Gel Confirming PCR Product 
 
 
 
5K bp 
 
3K bp 
 
2K bp 
 
 
 
1K bp 
 
Sirt1 = 1.6Kbp 
Nde1 Eag1 
1.6kbp 
We run PCR product through the 
Qiagen column to clean up and 
proceed to double digest. 
5’  C A T A T G  3’ 
3’  G T A T A C  5’ 
5’  C G G C C G  3’ 
3’  G C C G G C  5’ !
Reagents Added 
(Reaction 2) 
Volumes Used in Insert 
Digestion Mixture (µL) 
Volumes Used in Vector 
Digestion Mixture (µL)  
Water 10 30 
DNA 30 10 
BSA 0.5 0.5 
NEBuffer 3 5.0 5.0 
NdeI 2.5 2.5 
EagI 2.0 2.0 
Reagents Added 
(Reaction 1) 
Volumes Used in Insert 
Digestion Mixture (µL) 
Volumes Used in Vector 
Digestion Mixture (µL) 
Water - 35 
DNA 40 5.0 
BSA 0.5  0.5 
NEBuffer 3 5.0  5.0 
NdeI 2.5 2.5 
EagI 2.0  2.0 
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Ligation Protocols 
 
 Several methods were employed to determine the final concentration of 
digested vector and insert generated after gel extraction procedures. Prior to 
extracting the DNA fragments from the agarose gel for cleanup, an image was 
taken to qualitatively assess the relative concentration of insert to vector by the 
brightness of the bands. The absorbance spectra of 260 nm determined using 
the ND-1000 Spectrophotometer experiments allowed us to determine the ratio 
of digested insert to vector concentration. The Rapid DNA Ligation Kit was 
purchased from Thermo Scientific. The following components were necessary, 
10-100 ng of linearized pET28b(+) vector DNA, three fold molar excess of SIRT1 
insert over vector (variable based on starting concentrations), 4 µL of 5x Ligation 
Buffer, 1 µL of T4 DNA Ligase, and nuclease-free water added to bring the 
reaction to a total volume of 20 µL. 
 Prior to addition of the reagents, the pET28b(+) vector, insert, and water 
were heated to 42 °C for 2 minutes in a warm water bath to ensure linearization 
of the vector. T4 DNA Ligase was added last and the reaction mixture was spun 
using a vortex and then centrifuged. The reaction was then incubated at room 
temperature for approximately 30 minutes. When older ligation kits were used for 
experiments, it was necessary to add 1 mM ATP to the reaction mixture. Without 
additional ATP as an energy source, ligation was ineffective. Control ligations 
were employed to test the efficiency of the ligation. Instead of adding insert to the 
 45 
reaction mixture, vector alone was added as a replacement to bring the final 
reaction volume to 20 µL (Figure 19). 
 
Figure 19. Ligation Product. Above, is the expected 6,791bp construct. Ligation 
of cut pET28b(+) vector and SIRT1 insert yields the plasmid of interest. The 
construct mapped above is the successful clone produced via simulated 
experiments using the software Clone Manager. The gray arrow represents the 
protein translated from the open reading frame that adds the 6x His-Tag to the 
SIRT1 protein product. 
 
Transformation Into a Bacterial Maintenance Strain 
 
 Two bacterial maintenance strains, TOP10 and DH5α, were tested in 
subsequent transformation reactions. Cells were homegrown using two methods. 
The first protocol called for competent cell preparation with TSS (Transformation 
and Storage Solution for chemical transformation) buffer. Pelleted cells were 
recovered according to standard protocols (28). The second method employed 
Ou  Sirt1-pET28 Construct 
Placed in frame with 
the His-tag so that our 
SIRT1 protein can be 
easily purified via Ni-
NTA column.  
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was the Inoue method. Cells were grown at lower ambient temperatures and 
prepared following protocols outlined in the literature (28).  
 Independent of the method, it was imperative to establish the 
transformation efficiency prior to experimentation. Commercially available 
pET28b(+) was transformed into 50 µL aliquots of prepared competent cells. 
Cells were plated on 50 µg/mL kanamycin sulfate-treated agar plates. Plated 
transformations were incubated at 37 °C overnight for 16-18 hours. The resulting 
colonies were counted and analyzed to determine the efficiency according to the 
literature (28). High efficiency cells were used in experiments. 
 The optimal experimental conditions required the addition of the entire 
ligation reaction to an aliquot of competent cells. The 20 µL ligation mixture was 
gently pipetted into the competent cells and stirred gently with the pipette tip. The 
cells were incubated on ice for 30 minutes and heat shocked for no more than 2 
minutes at 42 °C in a warm water bath. The tubes were immediately transferred 
to ice and 250 µL of SOC (Super Optimal Broth with the addition of 20 mM 
glucose) was added to the transformation reaction. The tube was capped tightly 
and incubated at a slant at 37 °C for 30 minutes. The reaction mixture was then 
plated on 50 µg/mL kanamycin plates and allowed to grow for 16-18 hours 
overnight.  
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5K bp  4K bp 
3K bp 
2K bp 
 
1K bp 
 
Sirt1=1.6Kbp pET28b=5.2Kbp 
Colony Analysis 
 Transformants were analyzed by growing select isolated colonies on a 
second antibiotic treated agar plate. The colonies were incubated at 37 °C for 16-
18 hours. Several daughter colonies were selected and amplified in 10 mL of LB 
broth treated with kanamycin. The plasmid was extracted using Qiagen Miniprep 
columns. The DNA was then double digested with Nde1 and Eag1 to verify the 
regeneration of the original DNA fragments (Figure 20).  
 
Figure 20. Ideal Analysis After Transformation. The above gel is the ideal 
analysis of daughter colonies. This simulated gel gives an indication of how the 
regenerated fragments should appear after plasmid extraction and double 
digestion. The SIRT1 is the lower band at 1.6 kbp and the pET28b(+) vector is 
the larger band obvious at 5.2 kbp.  
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RESULTS 
 
Expression of SIRT1 
 Initially the expression of SIRT1 from the SIRT1- pCMVSPORT6 plasmid 
was attempted. Standard plasmid extraction protocols were followed, to generate 
plasmid concentrations of approximately 600 ng/µL, concentrations that gave 
optimal results in later experiments. Typical plasmid concentrations amplified via 
DH5α cells are shown in Table 3. 
 
Table 3. Plasmid Extraction Results. After using Qiagen Miniprep columns to 
sequester the SIRT1-pCMVSPORT6 plasmid, concentrations were determined 
by testing each sample using the ND-1000 Spectrophotometer instrument. 
 
 
 
 
 
 
 
 
 Following extraction, the plasmid was digested with restriction enzymes 
Kpn1 and EcoR1. These readily available enzymes were compatible in the same 
buffer NEBuffer1. Using Clone Manager, the plasmid was modeled and was 
subjected to digestion with both enzymes. If the DNA isolated following double 
digestion was the construct of interest, two bands would be expected on agarose 
gel electrophoresis. Bands predicted by Clone Manager included DNA fragments 
DNA Extraction Data 
8-30-12 8-31-12 9-6-12 9-7-12 9-26-12 
[Culture # 1] (ng/µL)  149.0 197.3 108.9 574.1 448.2 
[Culture # 2] (ng/µL)  42.2 648.0 606.7 502.8 460.2 
[Culture # 3] (ng/µL)  83.3 337.8 600.0 535.3 485.8 
[Culture # 4] (ng/µL)  111.9 481.3 552.8 524.9 446.1 
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approximately 6 kbp and 1.6 kbp in size upon digestion of the plasmid with both 
Kpn1 and EcoR1 (Figure 21). 
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 Once the expected bands were visualized, higher concentration samples 
were submitted for sequencing. Sequencing data for SIRT1-pCMVSPORT6 was 
not available. Part of this experiment was to determine how the template was 
created. Sequencing data and experimental evidence aided in the determination 
of the SIRT1-pCMVSPORT6 plasmid sequence. The T7 Promoter Forward 
Primer was used for sequencing. The T7 promoter is approximately 100 base 
pairs upstream from the site of SIRT1 gene insertion. The sequencing results for 
the experimentally generated plasmid showed 100% homology with the known 
SIRT1 sequence.  The direction of the gene was opposite to that of the rest of 
the pCMVSPORT6 plasmid. Determination of the direction helped to confirm the 
overall understanding of the direction in which the SIRT1 gene was transcribed 
and subsequently translated. The sequence comparison shown below is initial 
construct generated by cloning software with the start codon of the SIRT1 gene 
adjacent to insert versus the confirmed SIRT1 gene sequence provided by 
PlasmID (Figure 22). 
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 Attempts were made to express SIRT1 from the extracted plasmid. Cells 
harboring the SIRT1-pCMVSPORT6 template were amplified using standard 
procedures. Cells were shown to replicate with high fidelity based on sequencing 
results. The SIRT1-pCMVSPORT6 were transferred into BL21®DE3™ 
expression cells. Transformed expression cells were amplified and induced to 
overexpress the SIRT1 protein under control of the T7 promoter.  
Pellets were collected at multiple time points from the culture induced by IPTG 
treatment. Expression levels were monitored by SDS gel electrophoresis of the 
chronologically loaded resuspended pellets (Figure 23). 
M  
 
t12hr 
 
C1 
 
t15hr 
 
C1 
 
t0hr 
 
C2 
 
t12hr 
 
C2 
 
t12hr 
 
C3 
 
t15hr 
 
C3 
 
t0hr 
 
C4 
t12hr 
 
C4 
t15hr 
 
C4 
 
t15hr 
 
C2 
 
t0hr 
 
C3 
t0hr 
 
C1 
205,000 Da 
116,000 Da 
84,000   Da 
55,000   Da 
45,000   Da 
14,200   Da 
6,500   Da 
9-
21
-1
2 110 kDa is where 
we expect to see 
our protein. 
 
 
Figure 23. Expression of SIRT1. This SDS gel provides very little information, 
as the 110kDa SIRT1 protein does not appear to be expressed at any time. The 
t0 represents the uninduced samples with t2 and t1 derived from the induced 
samples at 12 and 15 hours, respectively. We see no difference in band sizes 
between the uninduced and the induced cultures. Four cultures were induced 
and are represented as C1-4 respectively. 
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 Expression was repeated under the same conditions, with cell pellets 
collected from the induced cultures more frequently. Gel electrophoresis results 
again indicated a failure to observe the desired protein (Figure 24) . 
110 kDa is where 
we expect to see 
our protein. 
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-1
2 
 
 
Figure 24. Expression of SIRT1 Repeated.  Again, this SDS gel provides 
limited information, as the 110kDa SIRT1 protein is not present. Three cultures 
were prepared 1-3 respectively. Four pellets were obtained at hours 0, 2, 4, and 
8 respectively. 
 
Gene Cloning by PCR Amplification of SIRT1 
 Standard PCR protocols were followed (28). Following 200-fold dilution, 
the extracted SIRT1-pCMVSPORT6 served as template. The PCR product was 
characterized by electrophoresis of 0.75% agarose gel labeled with a standard 1 
kbp DNA ladder. The gel below (Figure 25) shows the product of an optimized 
PCR reaction using the outlined temperature settings (Figure 16) for Applied 
Biosystems Veriti 96 Well Thermal Cycler. 
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SIRT1 = 1.6 kbp 
12-14-12 
 
 
Figure 25. PCR Amplified SIRT1. Above is an agarose gel containing the 
amplified 1.6 kbp SIRT1 gene product from the SIRT1-pCMVSPORT6 template 
DNA. This gel was used to confirm that the PCR product was present in the 50 
µL PCR reaction. The rest of the reaction was applied to a Qiagen Gel Extraction 
column prior to double digestion. 
 
Double Digestion Using Eag1 and Nde1 
 After eluting PCR-amplified SIRT1 from the Qiagen Gel Extraction column, 
both the SIRT1 PCR product and the pET28b(+) vector were prepared for double 
digestion. Each digestion was setup simultaneously and incubated according to 
standard digestion procedures (28). The digested fragments of interest were 
separated from the other remaining smaller fragments by gel electrophoresis. 
The digested fragments were characterized by gel electrophoresis on a 0.75 % 
agarose gel (Figure 26). The double digestion was necessary to generate 
compatible sticky ends on both the insert and the vector fragments for ligation.  
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Analysis of Doubly Digested Products 
 
The first four lanes contain our Sirt1 
PCR product digested with both 
Eag1 and Nde1. The last two lanes 
is our double digested pET28b 
vector. 
 
The double digest removes 12 base 
pairs from the Nde1 side of the PCR 
product and 4 base pairs from the 
Eag1 side of the PCR product. 
 
The vector has unique sites for Nde1 
and Eag1 in the MCS. Once cut by 
both enzymes, 71 base pairs are 
removed.  
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3 kbp 
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SIRT1=1.6 kbp pET28=5.2 kbp 
1-18-13 
 
 
Figure 26. Vector and Insert Digestion with Eag1 and Nde1. The SIRT1 
digested product was highly concentrated after running through a single Qiagen 
Gel Extraction column. The SIRT1 also appears to have oligomerized as there 
are bands present above the expected 1.6 kbp band. The digested pET28b(+) 
appears at just above 5 kbp. Gels compared to uncut controls aided in 
determining if both enzymes were in fact cutting the vector.   
 
 The products of digestion were compared with the undigested controls to 
establish the efficacy of digestion. Confirmation of the DNA fragment digestion 
required the following experiments. Initial concerns were centered on the vector 
being cut appropriately. Restriction sites may be buried if the vector persisted in 
a supercoiled state. The vector was digested in the standard manner with the first 
reaction using only Eag1, then a second experiment only Nde1, and finally with 
both enzymes. The digestion products were compared with the uncut, 
supercoiled pET28b(+) vector by gel electrophoresis (Figure 27). 
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 Cut Eag1 Cut Nde1 Cut Eag1 and Nde1 
Uncut 
2-14-12 
 
 
Figure 27. Cut Vector Compared to Uncut Controls. The first lane is the 1 kbp 
marker the second lane is the vector-digested with Eag1. The third lane is the 
vector digested with Nde1. The fourth lane is the vector digested with both Nde1 
and Eag1. The fifth lane was the uncut, supercoiled pET28b(+). Due to 
decreased surface area the supercoiled vector had greater mobility through the 
agarose and therefore migrates farther and appears lower on the gel. 
 
 Similarly, the same experiment with SIRT1 insert assured the appropriate 
digestion occurred. Digestion reactions under standard conditions of the SIRT1 
insert with only Eag1, only Nde1, and both Eag1 and Nde1 were compared with 
undigested insert. Digested SIRT1 fragments were compared and analyzed by 
gel electrophoresis (Figure 28). Cleavage with Nde1 removes a greater number 
of base pairs as compared to cleavage with Eag1. Greater fragment mobility 
through the agarose gel indicates base pair removal. The fragment that was cut 
by both enzymes appears as the lowest band on the gel. 
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Digested Insert 
The following gel was 
run to test if the Sirt1 
PCR insert was being 
appropriated digested by 
each enzyme.  
 
The first and second 
lanes corresponds to our 
uncu t con t ro l . The 
second lane contains 
5uL of sample showing 
the high concentration 
yielded after 18 PCR 
react ions that were 
passed through the 
Qiagen column. 
 
The enzymes are cutting 
at the correct places and 
the migration of the 
bands on the gel are 
suggestive of this. 
 
Uncut Sirt1  
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Cut Eag1 Cut Nde1 Cut By Both 
Uncut Sirt1  
 
 
Figure 28. Cut Insert Compared to Uncut Controls. The first lane is the 1 kbp 
marker and the second lane is the uncut SIRT1 insert. The third lane is also the 
uncut insert except 5 times more concentrated. The fourth lane is the insert 
digested by Eag1, which cleaves 4 base pairs. The fifth lane is the SIRT1 
digested with Nde1, which excises 12 base pairs from the PCR-amplified insert. 
This band appears slightly lower than the previous digested product, which 
corroborates digestion. The sixth lane, digestion by both restriction enzymes to a 
total of 16 base pairs, migrates the farthest suggesting it is the smaller of the 
three digested bands.  
 
Ligation, Transformation, and Colony Analysis 
 Ligation was preformed according to outlined methods. Ligation products 
were transformed into both TOP10 and DH5α cells. Although numerous colonies 
were analyzed, Figure 29 illustrates the last result to date for regeneration of the 
1.6 kbp SIRT1 insert fragment and 5.2 kbp vector fragment. 
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pET28b=5.2Kbp 
  
 
Figure 29. Transformed Plasmid Digested with Eag1 and Nde1. Although the 
bands are fuzzy, it appears that this colony may in fact contain the clone that we 
hoped to achieve. 
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DISCUSSION 
 
Analysis of Results 
 Expression of the peptide product of the SIRT1 gene from commercially 
available SIRT1-pCMVSPORT6 was not successful. The 110 kDa band 
indicative of SIRT1 protein expression was not present in successive 
experiments (Figure 23, 24). These findings led to our investigation of the exact 
sequence of the clone and hence, the origin of the failure of protein expression. 
DH5α cells harboring the plasmid replicated the construct with high fidelity. 
Sequencing results (Figure 21, 22) and double digestion experiments showed 
that the SIRT1-pCMVSPORT6 could be amplified and replicated with almost 
100% homology. Sequence alignments of the experimentally derived SIRT1 
sequence with the known SIRT1 insert sequence provided evidence that the 
gene was intact and without spontaneous mutation.  
 Multiple double digestion experiments were utilized to confirm the 
presence of SIRT1 and the absence of mutation (Figure 21). With improved 
techniques, the plasmid could be digested reproducibly using Kpn1 and EcoR1 
restriction endonucleases to yield in the 6,334 bp and 1,334 bp fragments. It is 
clear that the starting template was replicated with high sequence homology to 
the known SIRT1 sequence. Interestingly, the sequence results showing that the 
poly-A tail was adjacent to the T7 promoter, were indicative of SIRT1 insertion in 
the opposite direction to the orientation previously inferred. A complete sequence 
was not provided with the commercially available clone however, sequencing 
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aided in a better understanding of the direction in which the clone was 
sequentially transcribed and then translated (Figure 30).  
 
Figure 30. Direction of the SIRT1 Sequencing Results. Using the T7 forward 
promoter primer it was expected that the start codon of the SIRT1 gene would be 
transcribed first. However, the poly-A tail was the first to be transcribed. The 
maroon arrow shows the direction the primer began sequencing to be the 
reverse direction to that shown on the map.  
 
 Expression experiments with IPTG, induced translation of proteins 
downstream of the T7 promoter. It is plausible that the directionality of the SIRT1 
insert made it difficult for the bacteria to successfully translate the SIRT1 protein 
from the promoter. These findings led to the redirection of the investigation 
towards alternative approaches to SIRT1 expression. Multiple experiments to 
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digest the template and ligate the full SIRT1 insert into the bacterial vector 
pET28b(+), proved unsuccessful. A more detailed investigation of the insert 
composition showed there are many non-protein coding regions within the 3,691 
bp SIRT1 insert. This suggests the difficultly the bacterial machinery may have 
encountered when attempting to transcribe and translate the human gene. 
Therefore, it was planned to isolate the SIRT1 protein coding region in its entirety 
via PCR amplification and clone that portion of the gene into pET28b(+).  
 To construct the primers for SIRT1 gene amplification from the 
pCMVSPORT6 template, a closer look at the bacterial vector was needed. The 
unique endonuclease restriction sites in pET28b(+) were considered. Similar 
sticky ends have higher probabilities for false pairing or for self-ligation. The 
endonuclease restriction sites Nde1 and Eag1 offered sufficient differentiation 
and were selected. Primers were designed that introduced the two restrictions 
sites at the termini of the sequestered SIRT1 gene to yield a SIRT1 PCR product 
of 1,690 bp. Successful PCR amplification of the SIRT1 gene yielded a visible 
1.6 kbp band (Figure 25).  
 As described in the outline of the cloning strategy, the vector and the 
insert were both doubly digested with Nde1 and Eag1 (Figs. 26, 27, 28). The 
digested insert consists of 1,674 bp and the digested vector 5,296 bp. 
Comparison of the gels to the undigested controls suggest that both the insert 
and vector are being cut. Fragments were ligated and transformed into both 
TOP10 and DH5α maintenance strains, with TOP10 yielding the most colonies. 
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Transformed colonies grown overnight were analyzed and the plasmids were 
harvested. The plasmids were treated with restriction endonucleases Nde1 and 
Eag1 to determine if the presence of bands used in clone construction appeared 
in the digestion mixture. The exhibited gel (Figure 29) shows that the SIRT1 
insert was successfully cloned into the pET28b(+) bacterial vector. 
 
Future Directions 
 The SIRT1-pET28b(+) plasmid will be sent for sequencing. Once 
confirmed that the sequence is correct, the clone will then be transformed into an 
expression cell. Rosetta Gami cells by Novagen are useful as they can translate 
codons coding for rare amino acid residues. The SIRT1 protein has several rare 
codons suggesting the utility of Rosetta Gami expression cells in experiments. 
Glycerol stocks will be obtained once the SIRT1-pET28b(+) plasmid is hosted in 
the expression system. The cells will be amplified, induced, and the protein 
extracted. The protein can then be purified using standard metal ion 
chromatography purification methods.  
 Activity will be assessed by comparative studies between the 
experimentally derived SIRT1 enzyme versus commercially available SIRT1 
enzyme. Confirmation of active enzyme allows for competition and binding 
studies. These studies can be done in conjunction with inhibition studies using 
both native inhibitors as well as relevant chemotherapeutic agents. 
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 The SIRT1 enzyme is known to interact with a variety of biomolecules and 
has been found to act aberrantly in multiple disease states. Thus, understanding 
the binding site of clinical agents is imperative to develop improved, efficacious 
compounds. Since most enzymes work in concert in multicellular organisms, how 
these interactions fit into preexisting pathways is important. SIRT1 is known to 
bind key regulators of the host immune response. The known tumor suppressor 
gene, p53, is a substrate on which both SIRT1 and Sir2 act. The conservation of 
this binding action over the course of natural selection is strongly indicative of the 
significance of the interaction. The primary aim of this project includes not only 
characterization of SIRT1 binding native inhibitors but also the affect of key 
clinical agents on the host immune response to infection.  
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